Dispersed Systems
Dispersed Systems
Dispersed Systems
LIQUIDS
MDALegaspi 2016
MDALegaspi 2016
DRUGS
defined as an agent intended for use in the
diagnosis, mitigation, treatment, cure, or
prevention of disease in humans or in other
animals (Food, Drug, and Cosmetic Act, 1938)
MDALegaspi 2016
Drug product
means a finished dosage form, for example,
tablet, capsule, solution, etc., that contains an
active drug ingredient generally, but not
necessarily, in association with inactive
ingredients (CFR21)
The term also includes a finished dosage form
that does not contain an active ingredient but is
intended to be used as a placebo.
MDALegaspi 2016
Component
means any ingredient intended for use in the
manufacture of a drug product, including those
that may not appear in such drug product
MDALegaspi 2016
Except
PLACEBO
w/c do not
contain AI
Active Ingredients
+
Inactive Ingredients
MDALegaspi 2016
MDALegaspi 2016
Inactive ingredient
means any component other than an active
ingredient
AKA: Excipients/ Additives/Pharmaceutical
Adjuncts/Necessities
MDALegaspi 2016
Inactive ingredient
are agents used to :
Solubilize
Suspend
Thicken
Dilute
Emulsify
Stabilize
Preserve
Color
Flavor
MDALegaspi 2016
MDALegaspi 2016
DOSAGE FORM
Formulation containing a specific quantity of
active ingredient(s)in combination with one or
more excipients
Powders and
Granules
MDALegaspi 2016
Solid
Capsules
Tablets
Solutions
Liquid
Dispersed
Systems
Ointments
Creams
Semisolid
Gels
Gas
TDDS
MDALegaspi 2016
LIQUIDS
MDALegaspi 2016
SOLUTIONS
Aqueous
solutions
Non-Aqueous
Solutions
Aromatic water
MDALegaspi 2016
Aqueous Solutions
Aqueous Acids
Diluted Acids
Douches
Enemas
Gargles
Washes
Mouthwashes
Juices
Otic Solutions
Solutions
Nasal Solutions
Irrigation
Solutions
Sprays
MDALegaspi 2016
Sweet and
other Viscid
Aqueous
Solutions
Syrups
Honeys
Mucilage
Jellies
Collodions
MDALegaspi 2016
NON-AQUEOUS
SOLUTIONS
Elixirs
Glycerins
Inhalations and
Inhalants
Liniments
Oleovitamins
Spirits
MDALegaspi 2016
LIQUIDS
Dispersed Systems
MDALegaspi 2016
Coarse
Dispersion
Fine
Dispersion
Suspensions
Emulsions
Magmas
Gels
MDALegaspi 2016
SOLIDS
CAPSULES
MDALegaspi 2016
Hard Gelatin
Capsules (HGC)
Soft Gelatin
Capsules (SGC)
MDALegaspi 2016
SOLIDS
TABLETS
Compressed Tablets
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
Dispersed Systems
types of liquid preparations containing
undissolved or immiscible drug distributed
throughout a vehicle
In these preparations, the substance distributed
is referred to as the dispersed phase, and the
vehicle is termed the dispersing phase or
dispersion medium
Suspensions
Coarse
Dispersion
MDALegaspi 2016
Emulsions
Dispersed
Systems
Magmas
Fine
Dispersion
Gels
MDALegaspi 2016
Coarse Dispersion
Dispersions containing coarse particles, usually
10 to 50 m
consist of at least two phases
dispersed or internal phases (one or more )
dispersion medium or vehicle (continuous or
external phase )
Preparations:
suspensions
emulsions
MDALegaspi 2016
Fine Dispersion
Dispersions containing particles of smaller size
(0.5 to 10 m)
Preparations:
Magmas
Gels
MDALegaspi 2016
MDALegaspi 2016
SUSPENSIONS
defined as preparations containing finely
divided drug particles (the suspensoid)
distributed somewhat uniformly throughout a
vehicle in which the drug exhibits a minimum
degree of solubility
MDALegaspi 2016
SUSPENSIONS
are two-phase system consisting of an
undissloved or immiscible material dispersed in
a vehicle (solid, liquid, or gas).
coarse dispersion containing finely divided drug
particles distributed uniformly throughout the
vehicle in which the drug exhibits a minimum
degree of solubility
requires suspending and dispersing agents to be
diluted and agitated with a specified quantity of
vehicle, usually purified water
MDALegaspi 2016
SUSPENSIONS
the particle diameter is 1 to 50 m
Availability:
Oral Suspension are available as dry
powders intended for suspension in liquid vehicles
for Oral Suspension are most frequently
supplied as dry powder mixtures for
reconstitution at the time of dispensing
MDALegaspi 2016
MDALegaspi 2016
Features Desired in a
Pharmaceutical Suspension
1. A properly prepared pharmaceutical
suspension should settle slowly and should be
readily redispersed upon gentle shaking of the
container
2. The particle size of the suspensoid should
remain fairly constant throughout long periods
of undisturbed standing
3. The suspension should pour readily and evenly
from its container
MDALegaspi 2016
MDALegaspi 2016
Stokes equation
was derived for an ideal situation in which
uniform, perfectly spherical particles in a very
dilute suspension settle without producing
turbulence, without colliding with other particles
of the suspensoid, and without chemical or
physical attraction or affinity for the dispersion
medium
MDALegaspi 2016
Brookfield viscometer
Measures viscosity by the force required to
rotate a spindle in the fluid being tested
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
Micropulverization
one of the most rapid, convenient, and
inexpensive methods of producing fine drug
powders of about 10 to 50 m size
Micropulverizers are high-speed attrition
or impact mills that are efficient in reducing
powders to the size acceptable for most oral and
topical suspensions
MDALegaspi 2016
Micropulverization METHODS:
fluid energy grinding
spray drying
MDALegaspi 2016
MDALegaspi 2016
spray drying
produces particles of extremely small
dimensions
Spray Dryer is a cone-shaped apparatus
into which a solution of a drug is sprayed and
rapidly dried by a current of warm, dry air
circulating in the cone
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
Wettability Property
Involves the affinity of the solid and the liquid
portion of the suspension
Aids to increase the wetting characteristics of
powder:
1. Use of Surfactant to decrease the solid-liquid
interfacial tension
2. Use dispersion aids for hydrophobic solids
Example:
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
Flocculated System
Aka: Coagulated System or Colloidaly Unstable
System
Characteristics:
a) particles appears as floccules or like tufts of
wool with loose fibrous structure
b) Forms a clear particle free supernatant liquid
and a sediment
c) Exhibit a minimum of serious separation
MDALegaspi 2016
Deflocculated System
Aka: Peptized System or Colloidaly Stable
System
Characteristics:
a) The particles settle as a dense sediment and
becomes compact after a given time interval
b) Results in poor suspension
MDALegaspi 2016
5.
DEFLOCCULATED
1.
2.
3.
4.
5.
MDALegaspi 2016
Sedimentation Rate
The velocity of sedimentation is directly
proportional to the particle size and inversely
proportional with the viscosity of the
formulation
MDALegaspi 2016
Problems in Suspension:
1. Caking
formation of cement like substance due to small
partcles
Irreversible process
Solution: Flocculated System
2. Sedimentation
The rapid settling of particles
Reversible Process
Solution: Suspending Agents
MDALegaspi 2016
Rheology
the study of flow, addresses the viscosity
characteristics of powders, fluids, and semisolids
Two (2) general categories of materials flow:
1. Newtonian flow is characterized by
constant viscosity, regardless of the shear rates
applied
2. non-Newtonian is characterized by a
change in viscosity characteristics with
increasing shear rates
Example materials include colloidal solutions,
emulsions, liquid suspensions, and ointments
MDALegaspi 2016
MDALegaspi 2016
Plastic
Substances that exhibit plastic flow are called
Bingham bodies
Plastic flow does not begin until a shearing
stress corresponding to a certain yield value is
exceeded
MDALegaspi 2016
Pseudoplastic
Pseudoplastic substances begin flow when a
shearing stress is applied; therefore, they exhibit
no yield value.
With increasing shearing stress, the rate of shear
increases; consequently, these materials are also
called shear-thinning systems
MDALegaspi 2016
Dilatant
Dilatant materials are those that increase in
volume when sheared, and the viscosity
increases with increasing shear rate.
These are also called shear-thickening
systems.
Dilatant systems are usually characterized by
having a high percentage of solids in the
formulation.
MDALegaspi 2016
MDALegaspi 2016
Formulation of Suspensions
Factors to be considered in formulating
suspensions:
1. Type of suspension desired (flocculated or
deflocculated)
2. Formulation adjuvants
3. Preparation techniques
4. Incompatiblities
MDALegaspi 2016
Type of suspension
Flocculated System
Deflocculated System
MDALegaspi 2016
Formulation adjuvants
Dispersion medium
Wetting agents
Buffer
Other adjuvants:
Preservatives
Colorants
Flavorants
Perfumes
MDALegaspi 2016
Methods of Manufacture/Preparation
of Suspension:
1. By dispersion method
2. By precipitation method
MDALegaspi 2016
Incompatibilities
Formation of dark color
Oil separation
Chemical reaction
MDALegaspi 2016
MDALegaspi 2016
Purposes of Suspension
Sustaining effect
Stability
Taste
Basic solubility
MDALegaspi 2016
Application of Suspension
MDALegaspi 2016
Formation of suspensions
The following steps may minimize stability problems
1.
The particle size of all powders used in the formulation should be
reduced.
2. A thickening (suspending) agent may be used to increase viscosity.
Common thickening agents include alginic acid, bentonite, VEEGUM,
methylcellulose, and tragacanth.
3. A levigating agent may aid in the initial dispersion of insoluble particles.
Common levigating agents include glycerin, propylene glycol, alcohol,
syrups, and water.
4. Flavoring agents and preservatives should be selected and added if the
preparation is intended for oral use. Common preservatives include
methylparaben, propylparaben, benzoic acid, and sodium benzoate.
Flavoring agents may be any fl avored syrup or flavored concentrate
5. The source of the active ingredients (e.g., bulk powders vs. tablets or
capsules) must be considered; if commercial dosage forms are used, the
inactive ingredients must be considered and only immediate-release
tablets or capsules should be used and not modified release, unless
necessary and they can be used appropriately.
MDALegaspi 2016
Preparation of suspensions
1.
2.
3.
4.
5.
6.
7.
8.
MDALegaspi 2016
Function
6g
Antacid
Sodium benzoate
0.5g
Preservative
Sodium saccharin
0.005g
Sweetener
Sorbitol
1.4 mL
Viscosity builder
Peppermint oil
0.005 mL
flavorant
Purified water,
to make 60 mL
Solvent
MDALegaspi 2016
MDALegaspi 2016
EMULSION
is a dispersion in which the dispersed phase is
composed of small globules of a liquid distributed
throughout a vehicle in which it is immiscible
have dispersed particles ranging in diameter from
0.1 to 100 m
is a dispersed system containing at least two
immiscible liquid phases
Two (2) phases:
MDALegaspi 2016
Types of Emulsion
1)
2)
3)
4)
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
multiple emulsions
three phases are present
Forms:
W/O/W
O/W/O
MDALegaspi 2016
Microemulsions
appear translucent or
transparent
have droplet diameter
in the nanometer size
range
MDALegaspi 2016
2. Conductivity Test
3. Dye-solubility Test
MDALegaspi 2016
3. Order of mixing
the phase that is being added by portions tends to
be the internal phase
MDALegaspi 2016
Purposes of Emulsion:
MDALegaspi 2016
Emulsifying Agent
Any compound that lowers the interfacial tension
and forms a film at the interface can potentially
function as an emulsifying agent.
The effectiveness of the emulsifying agent depends
on its chemical structure, concentration, solubility,
pH, physical properties, and electrostatic effect
MDALegaspi 2016
MDALegaspi 2016
Plant:
Acacia
Tragacanth
Pectin
cellulose derivatives
MDALegaspi 2016
Acacia
forms a good, stable emulsion of low viscosity
It tends to cream easily, is acidic, and is stable at
a pH range of 2 to 10.
Like other gums, it is negatively charged,
dehydrates easily, and usually requires a
preservative.
It is incompatible with Peruvian balsam,
bismuth salts, and carbonates
MDALegaspi 2016
Tragacanth
forms a stable emulsion that is coarser than
acacia emulsion
It is anionic, is difficult to hydrate, and is used
mainly for its effects on viscosity.
Less than 1/10 of the amount used for acacia is
needed.
MDALegaspi 2016
Agar
is an anionic gum that is primarily used to
increase viscosity.
Its stability is affected by heating, dehydration,
and destruction of charge.
It is also susceptible to microbial degradation.
MDALegaspi 2016
Pectin
is a quasi-emulsifier that is used in the same
proportion as tragacanth
MDALegaspi 2016
Gelatin
provides good emulsion stabilization in a
concentration of 0.5% to 1.0%
It may be anionic or cationic, depending on its
isoelectric point.
Type A gelatin (+), prepared from an acid-treated
precursor, is used in acidic media.
Type B gelatin (-), prepared from an alkali-treated
precursor, is used in basic media.
MDALegaspi 2016
Methyl cellulose
is nonionic and induces viscosity.
It is used as a primary emulsifier with mineral
oil and cod liver oil, and yields an o/w emulsion.
It is usually used in 2% concentration.
MDALegaspi 2016
Carboxymethylcellulose
is anionic and is usually used to increase
viscosity
It tolerates alcohol up to 40%, forms a basic
solution, and precipitates in the presence of free
acids.
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
MDALegaspi 2016
HYDROPHILICLIPOPHILIC BALANCE
(HLB)
HLB Value Range
Surfactant Application
03
Antifoaming agents
46
79
Wetting agents
8 18
13 - 15
Detergents
10 - 18
Solubilizing agents
MDALegaspi 2016
MDALegaspi 2016
Preparation
A. Classical, acacia-stabilized emulsions are
prepared by one of the following four methods:
1.
2.
3.
4.
MDALegaspi 2016
MDALegaspi 2016
b.
i.
MDALegaspi 2016
Bottle method
a variation of the dry gum method used for
volatile oils
Oil is added to the acacia in a bottle.
The ratio of oil, water, and acacia should be 3:2:1
or 2:1:1.
The low viscosity of the volatile oil requires a
higher proportion of acacia.
MDALegaspi 2016
b.
c.
MDALegaspi 2016
2.
a.
3.
The two phases are heated to 70 to 80C and then combined with
stirring until the resultant emulsion has cooled.
In general, heat-labile or volatile ingredients should not be
incorporated in the separate phases but in the resultant emulsion aft
er it has cooled to about 40C or less.
MDALegaspi 2016
MDALegaspi 2016
2.
3.
4.
Occasionally, a small amount of oily material is added if excess emulsifier was used in the
original formation.
A small amount of an oil-soluble drug can be added if it is dissolved in a very small
quantity of oil with geometric dilution techniques.
MDALegaspi 2016
MDALegaspi 2016
Masking Flavor
Salt
Butterscotch, maple
Bitter
Sweet
Acid
Citrus
MDALegaspi 2016
PROBLEMS IN EMULSION
1. creamingupward
2. sedimentationdownward
3. aggregationglobules come together but do
not fuse
4. coalescenceglobules come together and
fuse
5. crackingcomplete separation
6. inversion o/ww/o vice versa
MDALegaspi 2016
GELS
are semisolid systems consisting of dispersions
of small or large molecules in an aqueous liquid
vehicle rendered jelly-like by the addition of a
gelling-agent
MDALegaspi 2016
PHENOMENA IN GELS
Thixotropy is the ability of the gel to become fluid
on agitation, only to resume their solid or semisolid
state after remaining undisturbed for a period of
time.
Imbibition is the taking up of a certain amount of
liquid without a measurable increase in volume
Swelling is also the taking up of liquid by a gel but
with an increase in volume.
Syneres is phenomenon where liquid comes out of
the gel and the gel shrinks
Xerogel is formed when the liquid is removed from
a gel and only the frameworkremains
MDALegaspi 2016
GLYCEROGELATINS
are plastic masses containing
glycerin (40%)
water (35%)
gelatin (15%),
and an added medicinal substance (10%) such as
zinc oxide
MDALegaspi 2016
MAGMAS / MILK
A two-phase system gel consisting of floccules of
small distinct particles
ex. Milk of Magnesia / Magnesia Magma